Relatlimab
About
Therapy type: Immunotherapy
Therapy strategy: LAG-3 inhibition
Mappings
NCI Thesaurus: Relatlimab (ncit:C111999)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | PD-L1 < 1% | Melanoma | Nivolumab, Relatlimab |